News and Trends 30 Jun 2022
LG Chem renews license triggering $2M payment to Avacta
South Korean clinical stage biopharmaceutical company, LG Chem Life Sciences, has triggered a license renewal fee to UK-based oncology drug…
Clinical trial
- Latest Posts
News and Trends 29 Jun 2022
Encouraging results from respiratory diseases vaccine trial
A biopharmaceutical company developing vaccines against infectious diseases has announced positive results for people with life threatening respiratory diseases. Icosavax…
News and Trends 28 Jun 2022
Biogen, citing insurance challenges, shutters one of its Aduhelm studies
A company says it was forced to end an observational trial of Alzheimer’s drug, Aduhelm, after a ruling by US…
News and Trends 23 Jun 2022
Osivax gets €10M influenza vaccine grant
A grant of €10 million ($10.5 million) has been secured by pharmaceutical company Osivax to support a vaccine against influenza. …
ADVERTISEMENT
News and Trends 20 May 2022
Zealand Pharma’s drug for rare metabolic disease smashes phase III
After a year of slumping stock prices, Zealand Pharma is striking back, as its peptide drug improved blood sugar control…
News and Trends 8 Feb 2022
Reforms of EU Clinical Trial Regulations Bring Cautious Optimism
The EU’s clinical trial regulations received a major overhaul at the end of January 2022 to make trials easier to…
Sponsored by Link Medical
4 Jan 2022Why Biostatisticians are Essential for Successful Clinical Trial Management
The role of biostatisticians goes far beyond analyzing data at the end of a clinical study. Instead, they should be…
Sponsored by PSI CRO
15 Dec 2021Streamlining Clinical Trial Execution with Robotic Process Automation
Conducting clinical trials on time ensures that innovative treatments can reach patients in need. In the face of logistical challenges…
Opinion 10 Nov 2021
Automation Can Solve Diversity Issues in Clinical Trial Recruitment
How can we make clinical trial recruitment more reflective of the real world? Technology is coming to the rescue. The…
News and Trends 26 Oct 2021
Valneva’s Inactivated Covid-19 Vaccine Aces Phase III Trial
Last week, the French vaccine maker Valneva announced promising phase III trial results of its inactivated Covid-19 vaccine: a well-established…
News and Trends 8 Sep 2021
As J&J Vaccine Fails Phase II, the Quest for an HIV Vaccine Continues
Johnson & Johnson became the latest company to have a failed vaccine trial against HIV last week. While it was…
News and Trends 2 Sep 2021
AC Immune’s Mixed Phase II Results Buoy Alzheimer’s Research
An Alzheimer’s disease drug developed by AC Immune and Genentech has drawn conflicting phase II results this week, raising tentative…
News and Trends 29 Apr 2021
BMS’s Cancer Trial Showcases Potential for Checkpoint Inhibitors
Bristol Myers Squibb’s recent phase III success provided the first late-stage confirmation for a novel immune checkpoint target in nearly…
News and Trends 27 Apr 2021
EMA Approvals for Multiple Sclerosis Highlight Treatment Shortfalls
While the EU saw rapid-fire approvals in the multiple sclerosis space last month, the innovations centered mostly on improving existing…
Sponsored by LINK Medical
6 Apr 2021Data Management: Taking the Right Turn at the Clinical Trial Crossroads
The success of a new drug depends on much more than its efficacy and safety or the ingenuity of its…
Sponsored by Precision for Medicine
2 Feb 2021Sample Processing & Management – Hidden Success Factors in Clinical Trials
Standardized, carefully managed samples are indispensable for the success of any clinical study. Still, sample processing and management receive little…
ADVERTISEMENT
Sponsored by PCMG
8 Jun 2020Why Biotechs Should Invest in Good Outsourcing Management of CROs
The relationship between biotechs and their CRO partners has been long in the making. These days, a collaboration with CROs…
Sponsored by Vetter
2 Jun 2020Exploring the Evolving Role of CDMOs
In 2019, the global contract development and manufacturing organizations (CDMO) market was valued at about €139.9B ($151B). By 2025, it…
Expert Advice 12 Mar 2020
Five Challenges For Life Science Marketers in 2020
Developing a new drug has an estimated cost of €583M to €2.4B. Much of this spending goes towards companies, such…
18 Dec 2019
Biotechs, Here’s How to Make Your CRO Collaborations a Success!
As the complexity of drug discovery and development steadily increases, so do the costs. With average expenditures for prescription drug…
